This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Apr 28;106(5):dju095.

doi: 10.1093/jnci/dju095.

"TRIMing" the patient population to increase the benefit of mTOR inhibition

H Ian Robins¹, Mark E Burkard¹, Richard B Halberg²

Affiliations

Affiliations

¹ Affiliations of authors: Division of Hematology and Oncology (HIR, MEB) and Division of Gastroenterology and Hepatology (RBH), Department of Medicine, University of Wisconsin, Madison, WI.
² Affiliations of authors: Division of Hematology and Oncology (HIR, MEB) and Division of Gastroenterology and Hepatology (RBH), Department of Medicine, University of Wisconsin, Madison, WI. rbhalberg@medicine.wisc.edu.

PMID: 24777109
DOI: 10.1093/jnci/dju095

Editorial

"TRIMing" the patient population to increase the benefit of mTOR inhibition

H Ian Robins et al. J Natl Cancer Inst. 2014.

. 2014 Apr 28;106(5):dju095.

doi: 10.1093/jnci/dju095.

Authors

H Ian Robins¹, Mark E Burkard¹, Richard B Halberg²

Affiliations

¹ Affiliations of authors: Division of Hematology and Oncology (HIR, MEB) and Division of Gastroenterology and Hepatology (RBH), Department of Medicine, University of Wisconsin, Madison, WI.
² Affiliations of authors: Division of Hematology and Oncology (HIR, MEB) and Division of Gastroenterology and Hepatology (RBH), Department of Medicine, University of Wisconsin, Madison, WI. rbhalberg@medicine.wisc.edu.

PMID: 24777109
DOI: 10.1093/jnci/dju095

No abstract available

PubMed Disclaimer

Comment on

Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy.
Ong CA, Shannon NB, Ross-Innes CS, O'Donovan M, Rueda OM, Hu DE, Kettunen MI, Walker CE, Noorani A, Hardwick RH, Caldas C, Brindle K, Fitzgerald RC. Ong CA, et al. J Natl Cancer Inst. 2014 Apr 28;106(5):dju050. doi: 10.1093/jnci/dju050. J Natl Cancer Inst. 2014. PMID: 24777112 Free PMC article.

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

P30 CA014520)/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal